A range of bone regeneration strategies, from growth factor delivery and/or mesenchymal stem cell (MSC) transplantation to endochondral tissue engineering, have been developed in recent years. Despite their tremendous promise, the clinical translation and future use of many of these strategies is being hampered by concerns such as off target effects associated with growth factor delivery. Therefore the overall objective of this study was to investigate the influence of alpha-tricalcium phosphate (α-TCP) nanoparticle delivery into MSCs using a RALA cell penetrating peptide on osteogenesis in vitro and both intramembranous and endochondral bone formation in vivo. RALA conjugated α-TCP nanoparticle delivery to MSCs resulted in an increased expression of bone morphogenetic protein-2 (BMP-2) and an upregulation in a number of key osteogenic genes. When α-TCP stimulated MSCs were encapsulated into alginate hydrogels, enhanced mineralization of the engineered construct was observed over a 28 day culture period. Furthermore, the in vivo bone forming potential of RALA conjugated α-TCP nanoparticle delivery to MSCs was found to be comparable to growth factor delivery. Recognizing the potential and limitations associated with endochondral bone tissue engineering strategies, we then sought to explore how α-TCP nanoparticle delivery to MSCs influences early mineralization of engineered cartilage templates in vitro and their subsequent ossification in vivo. Despite accelerating mineralization of engineered cartilage templates in vitro, RALA conjugated α-TCP nanoparticle delivery did not enhance endochondral bone formation in vivo. Therefore the potential of RALA conjugated α-TCP nanoparticle delivery appears to be as an alternative to growth factor delivery as a single stage strategy for promoting bone generation.
Introduction
Bone tissue engineering approaches commonly use temporary matrices in the form of scaffolds and hydrogels loaded with growth factors and/or exogenous mesenchymal stem cells (MSCs) to enhance regeneration [1] [2] [3] [4] . To date two distinct strategies have been employed to engineer functional bone using MSCs. The most commonly adopted approach is the direct conversion of MSCs in the engineered construct to bone forming cells, the deposition of bone specific matrix followed by its mineralization through simulating the process of intramembranous ossification. This is commonly implemented by employing hydrogels or scaffolds loaded or stimulated with growth factors that induce osteogenic differentiation of the incorporated or recruited MSCs [5] [6] [7] [8] . An alternative approach is the engineering of a hypertrophic cartilaginous template by inducing chondrogenic lineage differentiation in bone marrow derived MSCs in order to recapitulate the developmental process of endochondral ossification [9] [10] [11] .
Several studies have convincingly demonstrated the potential of these approaches for functional bone regeneration, however a number of challenges remain. A well-documented concern relates to undesired side-effects associated with the supra-physiological delivery of growth factors in vivo 12, 13 . Alternatively, when MSCs or engineered tissues are delivered to a site of bone injury, the immediate low-oxygen environment which is typical at the implantation site can negatively affect their survival rate 14, 15 . Bone regeneration via an engineered cartilage template (endochondral tissue engineering) can theoretically addresses the challenges associated with growth factor delivery and the survival of cells as chondrocytes are better equipped to remain viable within such low-oxygen conditions. In addition, hypertrophic chondrocytes are known to produce pro-angiogenic factors which is advantageous for vascularization of the construct [16] [17] [18] . However, matrix mineralization using this approach largely depends on initiating a specific sequence of temporal molecular and cellular events starting from hypertrophy of chondrocytes, invasion of blood vessels, migration of osteoprogenitors and matrix mineralization 16 . The need for relatively longer in vitro culture periods for chondrogenic priming is also regarded as a hurdle that needs to be overcome to enable clinical translation of such approaches. Therefore investigating alternative strategies that facilitate control over stem cell lineage differentiation for functional bone formation (whether via intramembranous or endochondral pathways) is critical to developing more translational approaches to bone tissue engineering.
The use of osteoinductive biomaterials to control stem cell fate has been well documented in the literature 19 . Calcium phosphate (CaP) based materials such as hydroxyapatite (HA) and α-or β-tricalcium phosphate (α-TCP, β-TCP) have been extensively investigated as scaffolding materials for bone regeneration and many of them are in clinical use [20] [21] [22] [23] [24] 
Materials and methods

Experimental design
This study was designed to investigate the osteogenic effect of delivering α-TCP nanoparticles conjugated to a RALA delivery peptide (hereafter known as RTCP) to MSCs. MSCs were either encapsulated in empty or growth factor (GF) loaded cell adhesion motif arginyl-glycylaspartic acid (RGD) 40 conjugated alginate hydrogels. Three systematic in vitro studies and two in vivo studies were performed. The composition of the hydrogels used in this study is summarized in Table 1 Table 2 .
RTCP nanoparticle formulation
The synthesis of α-TCP and formulation of RTCP nanoparticles were carried out as we previously reported 41 Briefly, α-TCP (Ca3(PO)4) nanoparticles were prepared using dicalcium phosphate (2CaHPO4) and calcium carbonate (CaCO3) Prepared nanoparticles were conjugated with RALA peptide by adding RALA (Biomatik, USA) and α-TCP in a ratio of 5:1, in ultra-pure water. Nanoparticles were allowed to form by spontaneous electrostatic interactions between the cationic peptide and anionic CaP at room temperature for approximately 30 min. Prepared RTCP nanoparticles were stored at 4 o C for a period of 2-4 weeks before usage.
MSC culture and intracellular delivery of RTCP.
Bone marrow derived porcine MSCs were isolated according to a modified method developed for human MSCs 43 , expanded and cryopreserved as previously described 44 . Cryopreserved 
Gene expression analysis
RTCP delivered MSCs and control MSCs were plated at a density of 5x10 5 cells per well in a 6-well plate and were incubated in cell neutral media (CNM) composed of hgDMEM supplemented with 3% FBS, 100 U mL -1 penicillin-100 μg mL -1 streptomycin and 2.5 μg mL Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes. Porcine specific primer sequences KiCqStart® SYBR® Green Primers; Sigma, Ireland) that were used for amplification of these genes are listed in Table 3 . Comparative Threshold (cT) data were analysed using the ΔΔCT method as described previously 45 with GAPDH as the endogenous control. Relative expression of the genes is presented as fold changes relative to the control group.
Preparation RGD-γ alginate and encapsulation of MSCs
Gamma-irradiated (5 Mrad) RGD modified alginate (hereafter known as RGD-γ-alginate) was prepared as previously reported 46 . Briefly, RGD peptides were covalently conjugated to γ -irradiated alginate using aqueous carbodiimide chemistry followed by purification and sterilization as previously described 47, 48 . A 4% solution of RGD alginate was prepared in ultrapure water by stirring overnight in a 50 mL falcon tube aseptically. RTCP-MSC and control MSCs were prepared as mentioned above (2.3) and were suspended at a cell density of 20 x 10 6 MSCs mL -1 within RGD-γ-alginate (2%). To cast cylindrical hydrogels (5 mm diameter x 3 mm height) MSC-RGD-γ-alginate hydrogel solution was pipetted into sterile agarose (3% final) molds with a final concentration 50 mM CaCl2 and allowed to crosslink for 30 min at 37 o C.
In vitro culturing of tissue engineered hydrogels
MSCs encapsulated hydrogels were cultured in osteogenic, chondrogenic or neutral conditions for various studies in vitro. For osteogenic conditions, the hydrogel-cell constructs were maintained in CGM supplemented with 100 nM dexamethasone, 10 mM β-glycerol phosphate, and 0.05 mM ascorbic acid (all from Sigma-Aldrich, Ireland) at 20% O2 for 3 weeks. For chondrogenic conditions, tissue engineered hydrogels were maintained in CGM without FBS, supplemented with 100 µg mL -1 sodium pyruvate, 40 µg mL -1 L-proline, 50 µg mL -1 L-ascorbic acid-2-phosphate,1.5 mg mL -1 bovine serum albumin, 1X insulin-transferrin-selenium, 100 nM dexamethasone (all from Sigma-Aldrich, Ireland) and 10 ng mL -1 recombinant human TGF-β3
(ProSpec-Tany TechnoGene Ltd., Israel) for 3-6 weeks at 5% O2. For evaluating the intrinsic capability of RTCP-MSCs to form bone, and to evaluate the bone formation potential of GF delivery hydrogel in vitro, the hydrogel-cell constructs were maintained in CNM prepared as mentioned above (2.5) for 4 weeks. In all culture conditions, media change was performed twice weekly.
Cell viability assessment using live/dead staining
Live/dead staining at predetermined time points were performed using LIVE/DEAD™ viability/cytotoxicity assay kit (Invitrogen, Bioscience, Ireland) to evaluate the viability of MSCs in RTCP-MSC-hydrogel compared to that of C-MSC-hydrogel. Briefly, hydrogels were washed in PBS, sliced into halves and were incubated in 2 µM calcein AM and 4 µM ethidium homodimer-1-containing phenol-free DMEM (Sigma-Aldrich, Ireland). After 1 hour incubation, hydrogel-cell constructs were washed again in PBS and viability of encapsulated
MSCs were assessed using a scanning confocal microscope (Olympus FV-1000, UK) at an excitation and emission wavelengths of 515 and 615 nm. Analysis was performed in FV10-ASW 2.0 Viewer software.
In vivo subcutaneous implantation
All animal experiments were approved by the ethics committee of Trinity College Dublin and the Irish Medicines Board (IMB). Six different groups (Table 2) were subcutaneously implanted subcutaneously into the back of transgenic Balb/C nude mice (Harlan, UK) (n = 8) using a previously described surgical procedure 49 . For implantation, two subcutaneous pockets (one in the shoulder level and one in the hip level) were created per animal under ascetic conditions. Next, three hydrogel-cell constructs were implanted per pocket (n= 6 per mouse).
All the constructs were harvested at 8 weeks of in vivo implantation. Bone formation was analysed based on the gross appearance, micro computed tomography (µCT) scan, biochemical evaluation and histology.
µCT analysis
µCT scans were performed soon after implant retrieval. All samples were scanned with a high resolution µCT imaging system (Scanco Medical, Bassersdorf, Switzerland) at a resolution of 10 mm, a voltage of 100 kV, and current of 100 mA. Volumetric reconstructions and analysis of the acquired data were performed by NRecon and CT Analyzer software provided by SkyScan. A cylindrical volume centred over the defect covering the entire construct was selected as the volume of interest (VOI). A global threshold of 70-255 was used for analysing the constructs. Reconstructed 3D images generated from the scans were used to visualize mineral distribution throughout the constructs.
Biochemical analysis for sulphated glycosaminoglycan (sGAG), collagen and calcium content.
Hydrogel-cell constructs were digested with papain enzyme as previously reported 50 . Briefly, papain buffer extract (PBE) was prepared using 100 mM sodium phosphate buffer containing 0.1 M sodium acetate, 0.05 M ethylenediaminetetra-acetic acid, pH 6.0 (all from SigmaAldrich, Ireland). Papain (125 μg mL -1 , Sigma-Aldrich, Ireland) was activated with 10 mM cysteine hydrochloride immediately before usage. DNA content was quantified using Hoechst
Bisbenzimide 33258 dye assay (Quant-iT ssDNA Assay Kit, Biosciences). sGAG levels in the samples were measured using dimethylmethylene blue dye-binding assay, pH 1.35 (Blyscan, Biocolor Ltd., UK). For the collagen assay, papain digested samples were hydrolysed by treating with concentrated HCl (37%) and collagen content in the samples was quantified by measuring their hydroxyproline content using the Chloramine-T assay as previously described 51 . Acid digested hydrogel samples were used for the calcium assay. Briefly, hydrogel-cell constructs were digested with 1 M HCl and calcium in the samples was measured using standard calcium assay kit (Sentinel Diagnostics, Italy). Collagen and sGAG content in the constructs were normalised with DNA content and the calcium amount was normalised with the wet weight of the samples.
Histological evaluation of the constructs
Hydrogel-cell constructs were fixed in 4% paraformaldehyde (Sigma-Aldrich, Ireland) at the end of study periods, dehydrated and wax embedded in paraffin. Seven-µm thick sections were sliced from the paraffin embedded samples using a microtome (Leica, Germany). Sections were stained with aldehyde fuchsin/alcian blue (AF/AB) for visualizing sGAG, standard picrosirius red (PSR) for evaluating the collagen deposition, and alizarin red for evaluating the calcium deposition as previously described 9 . Semi-quantitative analysis of the stained area was performed using ImageJ (National Institute of Health).
Statistical analysis
Statistical analyses were performed by GraphPad Prism software (v.6, GraphPad, USA).
Quantitative findings are presented as mean ± SEM. Student's t-test was used to compare differences between two experimental groups. Multifactor analysis of variance (ANOVA) was performed followed by Tukey's multiple comparison test to determine statistical significance when comparison was made using more than two groups. The difference between groups was considered statically significant at p < 0.05.
Results
RALA conjugated α-TCP nanoparticle delivery results in upregulation of osteogenic genes in MSCs
Delivery of RTCP to MSCs in monolayer in vitro culture induced upregulation of osteogenic genes (Fig. 2) . Growth factor related genes such as BMP-2 and TGF-β3 showed significant upregulation in RTCP treated groups compared to controls at 1 week. The expression of these genes returned to levels similar to that of untreated controls after 2 weeks. The osteogenic transcription factor Runx-2 was found to be upregulated at week 2. The osteogenic marker genes collagen type 1 and osteocalcin were also found to be significantly upregulated after two weeks in RTCP treated MSCs compared to controls.
RALA conjugated α-TCP nanoparticle delivery to MSCs encapsulated in alginate hydrogels accelerates mineralization in vitro
RTCP-MSC remained viable over 4 weeks in vitro following encapsulation in alginate hydrogels, demonstrating comparable levels of viability to C-MSC (all groups maintained in media containing 3% serum with no other growth factors added to the media) (Fig.3 A) . H&E staining revealed similar levels of tissue deposition in both groups in CNM (Fig.3 B) . However, more intense alizarin red staining was observed in the RTCP-MSC-hydrogels. In agreement with histological findings, biochemical quantification confirmed significant increases in calcium deposition in the RTCP-MSC-hydrogels in comparison to C-MSC-hydrogels (Fig.3C ).
RALA conjugated α-TCP nanoparticle delivery to MSCs supports mineralization in both chondrogenic and osteogenic conditions
RTCP-MSCs remained viable in alginate hydrogels incubated in both chondrogenic and osteogenic culture conditions (Fig.4) . There was no difference between RTCP-MSC-hydrogels and C-MSC-hydrogels in terms of cell viability after 1 week in chondrogenic media or osteogenic media. Cells were found to be more aggregated in RTCP-MSC-hydrogels in comparison to C-MSC-hydrogels in chondrogenic culturing conditions (Fig.4 A) . RTCP-MSChydrogels appeared to contain a higher number of viable cells compared to controls when maintained in osteogenic media (Fig.4 B) . In agreement with this, the DNA content of RTCP-MSC hydrogels was higher in osteogenic conditions (Fig.4C) , while no significant differences in DNA content were observed in chondrogenic conditions (Fig.4D) .
RTCP-MSC maintained their capacity to undergo chondrogenic and osteogenic differentiation
following encapsulation in alginate hydrogels (Fig.5 ). In the presence of chondrogenic differentiation factors, RTCP-MSC-hydrogels contained similar levels of sGAGs and collagen to C-MSC-hydrogels (Fig.5 A) . Nodules of mineral were observed in RTCP-MSC-hydrogels maintained in chondrogenic conditions which were absent in C-MSC-hydrogels (Fig.5 A) . In the presence of osteogenic differentiation factors, staining for sGAG accumulation was more intense in RTCP-MSC-hydrogels, with no apparent differences in collagen accumulation as evidenced by picrosirius red staining. Staining for mineralization was more peripheral in CMSCs-hydrogels but more homogenous in RTCP-MSCs-hydrogels (Fig.5 B) .
The in vivo bone forming potential of RALA conjugated α-TCP nanoparticle delivery to MSCs is comparable to growth factor delivery
After 8 weeks in vivo, RTCP-MSC-hydrogels, C-MSC-GF-hydrogels and RTCP-MSC-GF-
hydrogels had all formed a mineralized, bone-like tissue, while little evidence of calcification was observed in C-MSC-hydrogels (Fig.6 . A and C). This was confirmed by microCT scanning, which revealed no statistically significant difference in mineral volume between the RTCP-
MSC-hydrogel, C-MSC-GF-hydrogel and RTCP-MSC-GF-hydrogel groups. The RTCP-MSC-
hydrogels contained significantly higher levels of mineral compared to the C-MSC-hydrogels (Fig.6 G) . The combination of RTCP delivery and growth factor delivery in RGD-alginate hydrogel did not lead to a synergistic increase in mineral deposition. Histological analysis showed a similar pattern of results when compared to the µCT findings. There was no evidence of bone-like tissue formation (haematoxylin/eosin staining) or mineralization (alizarin red staining) in C-MSC-hydrogels compared to the other three groups (Fig.6 B and D) . There was no statistically significant difference in collagen content among any of the groups (Fig.6E ).
Bone volume (quantified from histological images) was significantly higher following either RTCP delivery or growth factor delivery (Fig.6 F) .
Despite accelerating mineralization of engineering cartilage templates in vitro, RALA conjugated α-TCP nanoparticle delivery does not enhance endochondral bone formation in vivo
RTCP-MSC-hydrogels and C-MSC-hydrogels constructs were cultured for 6 weeks in chondrogenic growth conditions in vitro to engineer a cartilage template. Histological analysis revealed similar levels of sGAGs and collagen in both groups (Fig.7 A) , however RTCP-MSChydrogels contained higher levels of calcium (Fig.7A, B) . Bone formation in all chondrogenically primed constructs showed similar levels of bone formation 8 weeks after subcutaneous implantation (Fig.7 C) . There were no significant differences in collagen content and mineral volume between the groups (Fig.7 D) .
Discussion
The goal of this study was to investigate the potential of RTCP delivery to MSCs as a promising translational approach to generate engineered bone tissue. α-TCP nanoparticles conjugated to a RALA delivery peptide were prepared and delivered to MSCs prior to encapsulation into an RGD-modified alginate hydrogel. The results from this study support the hypothesis that delivering RTCP to MSCs accelerates mineralization in vitro and improves bone formation in vivo. Of note was the finding that the osteoinductive effect of RTCP delivery was similar to that of delivering a combination of growth factors (BMP-2 and TGF-β3) that was previously shown optimal for promoting bone formation 6 . In addition, RTCP delivery showed its potential to facilitate enhanced mineralization of engineered cartilage templates for endochondral bone formation strategies. Taken together, the results from this study demonstrate that a combinatorial approach involving MSCs and RTCP delivery has the potential to be used as a single stage strategy for bone regeneration without the need for exogenous growth factors.
Conjugation of α-TCP with a RALA peptide has previously been shown to improve the intracellular delivery of CaP nanoparticles 39, 41, 52 . Conjugation of the α-TCP nanoparticles to the RALA peptide limits agglomeration, with the suspension being stable for a period of 4 weeks at 4-37°C 41 . In addition, the presence of the cell penetrating peptide RALA acts to mitigate the hydrophilicity-associated negative effects linked to bare CaP nanoparticles 28 in terms of their capability to enter the cell membrane. CaP based biomaterials, including α and β-TCP, hydroxyapatite (HA) and calcium sulphate, have been extensively used in orthopaedics as a bone substitute material 26, 53, 54 . Nanoparticles in a size range of 20-200 nm has been shown to be optimal for intracellular delivery, with bare CaP nanoparticles often undergoing significant levels of agglomeration leading to development of a much larger particle size over time [55] [56] [57] [58] . Thus, currently CaP nanoparticles are largely used with modifications to increase their stability and to control their size in order to improve their capacity to cross the cell membrane 57 . Even though use of CaP based nanoparticles as carriers for intracellular delivery of nucleic acids has been explored for 40 years, the inherent osteogenic effect of calcium and phosphate ions released from such particles has not been considered in the majority of the studies. This is despite the fact that several studies have separately reported the osteoinductive properties of CaP based agglomerates and bulk scaffolding materials 26, 27, 59 .
RTCP delivery to MSCs lead to an upregulation of the master osteogenic transcription factor Runx-2 and other osteogenic genes (Fig. 3) which was preceded by an increase in BMP-2 expression. The potential of Ca2+ ions as osteoinductive cues is well established [29] [30] [31] . For example, a three-fold upregulation of BMP-2 in human bone marrow derived MSCs has previously been reported in response to high extracellular Ca2 + concentration 29 . Activation of protein kinase K (PKA) followed by Ras-MAP-kinase signalling pathway by Ca2 + ions which are internalized, possibly through type-L voltage-gated calcium channels, has been proposed as the possible mechanism of BMP-2 activation 29 . This confirms that BMP signalling is one of the key events in RTCP mediated osteogenesis in MSCs. In the case of intracellular delivery of CaP nanoparticles using RALA mediated delivery, Ca2 + ions can be readily available in the cytosol for activating PKA. A similar effect was observed after MSCs were encapsulated into alginate hydrogels, where α-TCP nanoparticle delivery also lead to increases in construct mineralization in vitro.
In addition to enhancing osteogenesis of MSC in vitro, RTCP delivery to MSCs induced similar levels of bone formation in vivo to that of growth factor delivery from hydrogels.
Incorporation of RGD to alginate has been previously shown to create attachment points to control phenotype, enhance cell-matrix interactions and promote differentiation into mature osteoblasts from mouse and human pre-osteoblasts 60, 61 and human MSCs 62 . In addition, delivery of BMP-2 from these low molecular weight hydrogels have been shown to robust bone regeneration in vivo 6, 63 . BMP-2 is long established as having potent osteoinductive properties 64, 65 , however there are well documented adverse outcomes associated with their use [66] [67] [68] . A recent review on the complications associated with BMP-2 delivery identified unanswered questions related to optimal dosing, repeat exposures, carcinogenesis and long-term results 12 .
The fact RTCP delivered to MSCs encapsulated within alginate hydrogels showed similar level of bone formation to that of growth factor delivery from hydrogels points to their use as an alternative to BMP-2 delivery for the repair of large bone defects. Further evaluation of these constructs in orthotopic defects is required to validate these proof-of-concept findings.
RTCP delivery to MSCs accelerated mineralization of the matrix within tissue engineered constructs maintained in non-specific culture conditions and those known to promote chondrogenesis and endochondral ossification. During bone formation, osteoblast produce bone specific extracellular matrix which is mineralized with HA nanocrystals 69 . The unique organization of mineralized collagen matrix provides structural integrity and mechanical strength to bone. The role of CaP-containing vesicles in the matrix mineralization has been previously established 28, [32] [33] [34] 70 . This suggested that the release of Ca 2+ and PO For example, it might enable shortening of the in vitro priming time necessary to engineer hypertrophic cartilage templates suitable for bone regeneration. Of note is the finding that the mineral volume of bony tissues generated in vivo from engineered cartilage templates was noticeably higher than that generated by either growth factor delivery or α-TCP nanoparticle delivery (compare Fig. 6 and Fig. 7) . Furthermore, these cartilaginous templates were noticeably more vascularized than other groups, suggesting that both nanoparticle and growth factor delivery strategies can be further improved to enhance their osteoinductivity.
In conclusion, the results of this study clearly demonstrate the osteo-inductive potential (G) Mineral volume quantified using µCT imaging (n=8, *P˂ 0.05). Histology scale bar low magnification 500 µm, high magnification 100 µm. Table 3 . Primer sequences used for real-time PCR
